Upon completion of the surgery, the patient received five digestive organs: liver, stomach, pancreas, duodenum and small intestine, according to a July 4 news release from the health system.
Anil Vaidya, MD, co-director of Cleveland Clinic’s intestinal transplant program, led the seven-surgeon team. He said there has been no evidence of cancer recurrence.
